Nanoform Finland Oyj (NANOFH.HE)
Helsinki · EUR · Healthcare · Biotechnology
€0.675 (-3.30%) as of
Key statistics
- Market cap
- 57.88M
- Forward P/E
- -6.14
- EPS (TTM)
- -0.1600
- Dividend yield
- 0.00%
- 52-week range
- 0.3770 – 1.2320
- Beta
- 0.88
- Revenue (TTM)
- 5.53M
- Profit margin
- -248.57%
- Analyst target
- €2.13
- Volume
- 32.85k
About Nanoform Finland Oyj
Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States. The company provides nanoforming technologies, formulation, and analytical services, including controlled expansion of supercritical solutions technology that enables the creation of active pharmaceutical ingredients (API) nanoparticles directly from solution; biological nanoforming technology; and dosage forms of Nanoparticles. It also offers STARMAP, an AI platform predicts the performance of your molecule in Nanoform's technology. The company was founded in 2008 and is headquartered in Helsinki, Finland.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Helsinki, Finland
- Employees
- 108
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.